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Flexible electrical aptasensor using 
dielectrophoretic assembly of 
graphene oxide and its subsequent 
reduction for cardiac biomarker 
detection
Abhinav sharma1 & Jaesung Jang2,3
Cardiac troponin T (cTnT) is considered a clinical standard for its high specificity and sensitivity when 
diagnosing acute myocardial infarction; however, most studies on the electrical sensors of cardiac 
troponin biomarkers have focused on cTnI rather than cTnT. This study presents label-free, low-cost, 
transparent, and flexible aptamer-based immunosensors for the electrical detection of cTnT using 
reduced graphene oxide (rGO) sheets. GO was first deposited by AC dielectrophoresis between two 
predefined source and drain electrodes on a 3-aminopropyltriethoxylsilane-modified polyethylene 
terephthalate substrate. The GO was then reduced using hydrazine vapour without damaging the 
substrate, resulting in uniform, controlled, and stable deposition of rGO sheets, and demonstrating 
more stability than those directly deposited by dielectrophoresis. Amine-modified single-strand DNA 
aptamers against cTnT were immobilized onto the rGO channels. The relative resistance change of this 
sensor owing to the attachment of cTnT was quantified as the cTnT concentration decreased from 10 ng/
mL to 1 pg/mL in phosphate buffered saline (PBS) and 10-fold diluted human serum in PBS, with the 
limits of detection being 1.2 pg/mL and 1.7 pg/mL, respectively, which is sufficiently sensitive for clinical 
applications. High-yield and rapid fabrication of the present rGO sensors will have significant influences 
on scaled-up fabrication of graphene-based sensors.
Cardiovascular disease is one of leading causes of mortality and morbidity globally. The statistics based on World 
Health Organization (WHO) showed that 17.9 million deaths were attributed to this disease in 20151, with 7.3 
million being due to acute myocardial infarction (AMI)2. Among several biomarkers for the detection of AMI, 
both cardiac troponins (I & T) are considered the “gold standard” owing to their high sensitivity and specificity 
for cardiac muscle damage3. A complex of cardiac troponins comprises cardiac troponin I (cTnI), cTnT, and 
cTnC, which are found in cardiac muscles, and both cTnI and cTnT are highly specific. In clinical practice, cTnT 
values provide an accurate diagnosis of absolute infarct size in AMI4. After the onset of AMI, the concentrations 
of the cardiac troponins begin to rise within 4–6 h, elevated up to more than two weeks for cTnT and more than 
5–7 days for cTnI5. In human serum, cTnT values <0.05 ng mL−1 are considered normal for AMI, values of 0.05–
0.09 ng mL−1 are considered borderline, and values ≥0.1 ng mL−1 are considered positive6. Despite the widespread 
use of cTnT and cTnI as diagnostic tools for AMI, commercially available cTnI immunoassay kits show large 
variations (at least a 5-fold difference) in the measured concentrations among them7. Moreover, complex forms 
of cTnI and its low stability could be problematic for developing new analytical methods. Therefore, cTnT assays 
may be more reliable for wider applications8,9.
Conventional immunoassays employed for the detection of cTnT include enzyme-linked immu-
nosorbent assay10, fluoroimmunoassay11, radioimmunoassay12, immunochromatographic tests13, and 
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electrochemiluminescence immunoassay14. However, these assays are usually time-consuming, expensive, and 
need multi-step processing of samples and good skilled staff.
In this regard, the development of low-cost, portable and sensitive biosensors is of significant interest for 
disease prognosis and diagnosis in hospitals and for point-of-care testing (POCT) applications15,16. Several immu-
nosensors have been presented for cTnT detection using different principles, such as surface plasmon resonance, 
electrochemical principles, etc. (Table 1). Although electrical immunosensors for cTnT detection have received 
little attention17–19, electrical sensors generally show several advantages, including simple measurements, easy 
miniaturization, and no necessity for complex instrumentation units20. Therefore, fabrication of electrical sensors 
on low-cost and flexible substrates would be highly desirable for POCT applications.
Recently, flexible substrate-based sensors have become key components of portable, low-cost, and wearable 
devices for POCT applications. Furthermore, many researchers have worked to fabricate flexible electrodes for 
flexible substrates so that the sensors can be applied to any curved surfaces. In this respect, graphene is a good 
candidate because it provides a high degree of flexibility with high conductivity and transparency21,22. To date, 
several approaches such as mechanical exfoliation23, chemical vapour deposition (CVD)24, thermal annealing of 
SiC25, and the arc discharge method26 have been developed to produce single and multiple layers of graphene. 
Among them, CVD is an extensively used approach to produce large-area graphene sheets; however, it is a 
high-temperature process, hence restricting the substrate choice and making it costly to scale up the production 
of graphene sheets. In contrast, solution processing of graphene oxide (GO) is a simple, cost effective, and efficient 
way of preparing graphene-based thin films. Solution-processing techniques include membrane filtration27,28, dip 
coating29, layer-by-layer assembly30,31, spray coating32, and spin coating33. These facilitate the production of a large 
quantity of graphene that is compatible with various substrates such as silicon and plastic; however, deposition at 
specific locations is still a challenging issue, and it is difficult to maintain the uniformity and thickness of the thin 
films with these methods34.
Dielectrophoresis (DEP) is an electrical method for the deposition and manipulation of micrometer- and 
nanometer-sized particles dispersed in a liquid35, and it has been successfully applied to thermally expanded 
Sensor platform/
Materials Sensor type
Recognition 
element/substrate Media
Measurement range/
Detection limit References
Nanostructured CNTs-PEI 
on an AuE Electrochemical (CV) Antibody/AuE PBS, Serum
0.1–10 ng mL−1 (PBS)
LOD–0.033 ng mL−1
0.02–0.32 ng mL−1 (Serum)
58
Polyaniline derivative 
poly-o-ABA modified 
electrode
Electrochemical (Chronoamperometry) Antibody/GCE PBS, Serum
0.05–10 ng mL−1 (PBS)
LOD–0.016 ng mL−1
0.025–7.5 ng mL−1 (Serum)
LOD–0.088 ng mL−1
59
MWCNTs modified with 
artificial Abs Electrochemical (Potentiometry) MIP Serum
1.41–20.86 µg mL−1
LOD–0.16 µg mL−1
9
N-MIP with co-polymer 
matrix rGO electrode 
surface
Electrochemical (DPV) MIP/SPE PBS, Serum
0.01–0.5 ng mL−1 (PBS)
LOD–0.006 ng mL−1
0.017–0.28 ng mL−1 
(Serum)
60
Nanostructured ZnO 
electrodes Electrochemical (EIS) Antibody/Polyimide Serum
0.0001 ng mL−1–
100 ng mL−1
LOD–1 pg mL−1 (Serum)
61
Two planar Al electrodes Capacitance measurement Antibody/SiO2/Si PBS, Serum
0.01–5 ng mL−1 (PBS),
0.07–6.83 ng mL−1 (Serum)
62
Gold substrate 
functionalized with SAM 
layer
SPR Antibody/AuE PBS 0.1–50 µg mL
−1
LOD–100 ng mL−1
63
Sandwich immunoassay 
with AuNPs Fluorescence Antibody Serum
0.25–14 nM
LOD–0.02 nM 
(0.7 ng mL−1)
11
cTnT-labeled MBs with the 
micro-fluxgate sensor Magnetic Antibody/Glass Serum
0.01–10 ng mL−1
LOD–0.01 ng mL−1
64
AuNPs immobilized on 
dithiol-modified surface QCM Antibody/Quartz Serum
0.003–0.5 ng mL−1
LOD–0.0015 ng mL−1
65
CMOS-compatible SiNW 
array Electrical Antibody/SOI PBS, Serum
0.000001–1 ng mL−1
LOD–1 fg mL−1 (PBS),
LOD–30 fg mL−1 (Serum)
18
DEP assembled rGO based 
flexible aptasensor Electrical Aptamer/PET PBS, Serum
0.001–10 ng mL−1
LOD–1.2 pg mL−1 (PBS)
LOD–1.7 pg mL−1 (Serum)
Present study
Table 1. Various types of immunosensors for detection of cardiac Troponin T. Abs: antibodies, Al: aluminium, 
AuE: gold electrode, AuNPs: gold nanoparticles, cTnT: cardiac troponin T, CMOS: complementary metal-oxide 
semiconductor, CNTs: carbon nanotubes, CV: cyclic voltammetry, DEP: dielectrophoresis, DPV: differential 
pulse voltammetry, EIS: electrochemical impedance spectroscopy, GCE: glassy carbon electrode, LOD: limit of 
detection, MBs: magnetic beads, MI: molecular imprinting, MWCNTs: multiwalled carbon nanotubes, N-MIP: 
nano-molecularly imprinted polymer, PBS: phosphate buffer saline, PEI: polyethyleneimine, poly-o-ABA: poly-
o-aminobenzoic acid, QCM: quartz crystal microbalance, rGO: reduced graphene oxide, SAM: self-assembled 
monolayer, SiNW: silicon nanowire, SPE: screen printed electrode, SPR: surface plasmon resonance, ZnO: zinc oxide.
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graphite oxide36, carbon nanotubes37–39, a few layers of graphene flakes and nanoribbons40, and a few layers (5–15) 
of reduced GO (rGO)41. DEP has many advantages, such as controlled deposition at specific locations, low cost, 
the ability to be performed at room temperature (RT), short deposition time (a few seconds), good thickness con-
trollability, and good uniformity40. This contrasts with other deposition approaches such as dip coating and drop 
casting on pre-treated self-assembled monolayers (SAM), where it would take several hours to deposit graphene 
and it is difficult to maintain uniformity and deposition of graphene at predefined location42,43.
This study demonstrates a low-cost, flexible, and label-free electrical aptamer-based immunosensor (aptasen-
sor) for cTnT detection using rGO sheets on a transparent substrate. GO was first deposited as a channel between 
source and drain electrodes using DEP onto a plastic [polyethylene terephthalate: (PET)] substrate with con-
trolled alignment. The GO was then reduced to rGO using hydrazine vapour. The fabrication of aptasensors using 
DEP deposition of GO sheets followed by reduction of the sheets has never been explored before, although both 
aptasensors and rGO have attracted considerable attention recently. In fact, aptamers have shown numerous 
advantages compared to antibodies, including no variation in batch-to-batch process, easy modification, fast and 
low-cost production with high flexibility, stability and specificity, making them ideal candidates for POCT appli-
cations44,45. Moreover, the present DEP-assembly of GO and its subsequent reduction produced more stable rGO 
sheets than those directly deposited by DEP, leading to uniform and smooth deposition of rGO sheets as a thin 
film on the flexible substrate46. The present electrical aptasensor holds the following advantages: low-cost, simple, 
and rapid fabrication at room temperature along with high yield, high sensitivity, flexibility, and reusability.
The rGO channel modified with a linker of 1-pyrenebutanoic acid succinimidyl ester (PBSE) was further 
functionalized with a DNA aptamer against cTnT. The relative resistance change (RRC) of the aptasensor caused 
by the attachment of cTnT to the channel was quantified as the cTnT concentration in human serum (10-fold 
diluted) and phosphate buffered saline (PBS) varied from 1 pg mL−1 to 10 ng mL−1. The sensitivity, selectivity, 
reproducibility, and reusability of the developed aptasensor will be discussed.
Results and Discussion
Characterization of as-deposited GO and reduced GO sheets between Cr/Au electrodes. The 
Raman spectra of the GO and rGO sheets between Cr/Au electrodes are shown in Fig. S1A,B, respectively. 
The Raman spectrum of the DEP-deposited GO showed a dominant D band (at 1350 cm−1) and G band (at 
1598 cm−1)47. The increased intensity of the D band for the rGO spectrum shows that sp2 structures of graphene 
or covalently attached functional groups were eliminated36.
The reduction of GO to rGO was also confirmed by XPS analysis (Fig. S2). The XPS data were collected from a 
thin film of GO and its reduced form rGO. The GO C1s XPS spectra demonstrate the bonding of carbon-oxygen 
functional groups such as C–C (284.6 eV), C–O (286.5 eV), C=O (287.6 eV), and O–C=O (288.9 eV)48. The 
atomic ratio of carbon to oxygen increased from ~1.8 to ~4.8 through reduction. The intensities of the C–O 
and C=O peaks also considerably reduced, and the O–C=O peak completely disappeared in the rGO spec-
tra (Fig. S2). This was closely associated with an increase in the sp2/sp3 carbon peaks, showing that many 
oxygen-containing groups were eliminated and the most of the sp2 carbon networks were restored. The addi-
tional peak of C–N groups at 285.8 eV shows that some nitrogen atoms were introduced from the reducing agent 
hydrazine41.
Aptasensors with micrometer-sized channel lengths and widths (L: 10 µm and W: 100 µm) between two Cr/Au 
electrodes were fabricated using wet etching on a PET substrate (Fig. S3). FE-SEM images of the DEP-assembled 
GO sheets before and after hydrazine reduction are shown in Fig. 1D,E, respectively. The GO sheets showed a lay-
ered structure consisting of ultrathin and homogeneous films. Because of the folding of these films, it was possible 
to recognize the edges of individual GO sheets with crumpled areas. After reduction, the rGO sheets were very 
smooth (Fig. 1E). This contrasts with those directly deposited by DEP (Fig. 1F), which resulted in many folds and 
wrinkles between the Cr/Au electrodes, making it difficult to measure the thickness of the rGO sheets. Figure 1G 
shows an FE-SEM image of a cTnT DNA aptamer-modified rGO surface, with many tiny clusters on the rGO sur-
face, demonstrating aggregates of cTnT aptamers49. Figure 1H shows a fluorescence image of FAM-modified cTnT 
aptamers on the rGO channel. The aptamers were selectively bound on the rGO surfaces via the PBSE linker, and 
the image clearly demonstrates that cTnT aptamers were deposited throughout the rGO sheets.
AFM images of the DEP-assembled GO sheets before and after reduction are shown in Fig. 2A,B, respectively. 
The rGO sheets connected the Cr/Au electrodes with fewer wrinkles and folds than the GO sheets. Figures 2C,D 
show surface profiles of the rGO sheets along three lines between two Cr/Au electrodes. Based on the measured 
profiles, we observed several bumps in the rGO sheets along lines 1, 2, and 3, and the thicknesses of the rGO 
sheets were approximately 6.22, 16.01, and 12.87 nm, respectively. Therefore, the thickness of the rGO sheets 
inside the channel was estimated to be in the range of 6–16 nm.
A suspension of rGO sheets, which was synthesized through the same process except that GO sheets were 
reduced using hydrazine solution instead of hydrazine vapour, was also drop-cast onto a flat silicon surface, and 
AFM images of the rGO sheets and their corresponding profiles were analysed to determine the thickness of a sin-
gle layer of rGO and hence the number of rGO layers deposited between the Cr/Au electrodes (Fig. S4). This was 
done because it was difficult to measure the thickness of a single rGO sheet between two Cr/Au electrodes when 
using DEP, despite the fact that the solution contained a large number of single-layered rGO sheets. The AFM 
measurements showed that the apparent thickness of the deposited single-layered rGO sheets varied from 1.2 nm 
to 1.5 nm. This is similar to the thickness of a single rGO layer reported in previous work41. These results demon-
strate that most of the rGO sheets deposited by DEP were few-layered (4–10 layers). Moreover, the transmittance 
of a bare PET substrate and of rGO sheets between Cr/Au electrodes on a PET substrate was approximately 91% 
and 76%, respectively (Fig. S5).
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Reduction of GO sheets using hydrazine solution did not etch the PET substrate and not harm the sensor 
characteristics. In contrast, hydrazine solution reacts with various types of materials including SiO2/Si substrate, 
with an etching rate (2 µm/min) on Si substrate50. This implies that a reduction process of GO sheets with hydra-
zine solution could be challenging for some device fabrication.
Electrical measurements of the rGO aptasensors after each functionalization. To examine the 
electrical properties of the rGO aptasensor, the resistance of DEP-assembled GO was first measured, and it was on 
Figure 1. (A) A schematic of the DEP-deposition of GO sheets on an APTES-modified PET substrate. (B) 
Schematic of the rGO aptasensors for the detection of cTnT, which consisted of rGO sheets (DEP-deposition 
of GO and its subsequent reduction) and cTnT aptamers on an APTES-modified PET substrate. (C) Schematic 
of cTnT aptamer immobilization on the graphene surfaces via PBSE linker and cTnT aptamers. Field emission 
scanning electron microscopy (FE-SEM) images of DEP-assembled thin layers of GO sheets (D) before and (E) 
after reduction via hydrazine vapour between two Cr/Au electrodes, (F) direct DEP deposition of rGO sheets, 
and (G) the immobilized cTnT aptamers on the rGO surface. (H) Fluorescence image of the immobilized cTnT 
aptamers on the rGO surface.
Figure 2. AFM images of DEP-deposited GO (A) and its reduced sheets (rGO) (B) between the two Cr/Au 
electrodes. (C) AFM image of the rGO surface. Lines 1, 2, and 3 represent the measuring lines between the Cr/
Au electrodes. (D) Height profiles of the rGO sheets along the three lines in (C) measured by AFM.
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the order of several MΩ. After reduction of the GO sheets using hydrazine vapour and mild annealing at 150 °C 
for 2 h, the resistance of the sensors was measured to be 10–30 kΩ. The I–V characteristics of the DEP-assembled 
thin layers of GO sheets before and after reduction via hydrazine vapour between two Cr/Au electrodes on PET 
are shown in Fig. S6. The I–V characteristics of the aptasensors were also measured at each step of functionaliza-
tion (Fig. S7). The I–V curves showed linear behaviour after each functionalization, showing good ohmic contact 
between the rGO sheets and the Cr/Au electrodes. The resistance of aptasensor increased after each functionali-
zation: linker (PBSE), cTnT aptamer, blocking buffer (ethanolamine), and cTnT (1 pg mL−1). This result demon-
strates that each binding event might change the electrical properties of the graphene sheets, causing reduction 
in charge-carrier density on the rGO surface. Moreover, binding of the lowest cTnT concentration (1 pg mL−1) on 
aptamer/rGO surface was observed through the change in I–V characteristics. This sufficient change in resistance 
shows the attachment of cTnT antigen on the rGO surface, and thus it may allow label-free detection of cTnT.
Sensitivity and selectivity studies in PBS and human serum. The sensitivity study of the rGO 
aptasensor was performed via measuring RRCs for various concentrations of cTnT. Figure 3 shows the RRCs 
of the rGO aptasensor with various concentrations of cTnT (1 pg mL−1–10 ng mL−1) in PBS (pH 7.4, 1×) and 
in human serum (10-fold diluted) in PBS (pH 7.4, 1×). The RRC increased significantly with increasing con-
centration of cTnT in both PBS and diluted human serum. This result shows that the specific cTnT aptamers 
fold as well-defined 3-D structure (loop formation) upon binding to complementary sequence of cTnT with 
high affinity51, allowing the change in RRC values. Moreover, cTnT protein adsorption on rGO sheets can affect 
drop-in conductance due to less electron-localization. Therefore, the modulation of the charge-carrier density 
might be a possible reason for change in resistance of the rGO sheets52. The developed aptasensor exhibited good 
fits [R2 = 0.96 for 1× PBS and 0.92 for human serum (10-fold diluted)] to the logarithm of cTnT concentrations 
(1 pg mL−1–10 ng mL−1) as compared to other immunosensors reported (Table 1). It should also be noted that 
RRCs in 1× PBS and 10-fold diluted human serum were shown to be linear (R2 = 93% and 86%, respectively) 
with respect to cTnT concentration from 1 pg mL−1 to 1 ng mL−1; however, as cTnT concentration increased more, 
RRCs started to be saturated. To support the electrical measurement, I–V curves for different concentrations of 
cTnT (1× PBS) were shown in supplementary information (Fig. S8)
Based on the interpolated graphs in Fig. 3 and the background noises, the detection limits for cTnT against 
the media (the signal-to-noise ratio = 3) were found to be 1.2 pg mL−1 for PBS (pH 7.4, 1×) and 1.7 pg mL−1 for 
human serum (10-fold diluted). Therefore, the present aptasensor is sensitive enough for clinical applications, 
considering that the detection limits of current ELISA kits are 10–30 pg mL−1 and the assay range is 10 pg mL−1–
10 ng mL−1 according to the datasheets53.
To examine the selectivity of the proposed rGO aptasensor toward cTnT detection, the RRCs were measured 
with other cardiac biomarkers, troponin I and myoglobin, in PBS (pH 7.4, 1×), and human serum (10-fold 
diluted) (Fig. 4). When high-concentration (1 µg mL−1) troponin I and myoglobin in the two media were added 
to the sensors, a very small change in the RRCs was observed compared to the RRCs obtained for the media alone. 
However, when 10 pg mL−1 of cTnT was added to the sensors, the RRCs showed rapid and sharp increases. The 
RRCs of this cTnT concentration were significantly different from those of the two media alone, but there were 
no significant differences between other cardiac biomarkers (cTnI and myoglobin) and the media alone. These 
results confirm that the developed rGO aptasensor has high selectivity toward cTnT.
Reusability and reproducibility of the aptasensor. Figure 5 shows RRC (ΔR = (R − R0)/R0) with recy-
cling of the aptasensors, where R is the resistance of either new or reused aptasensor after cTnT immobilization, 
Figure 3. Relative resistance change (RRC) of the aptasensors as the concentration of cTnT in PBS (pH 7.4, 
1×) and 10-fold-diluted human serum was varied from 1 pg mL−1 to 10 ng mL−1. The error bars indicate the 
standard deviations of the measurements. The inset shows the measurements from 1 pg mL−1 to 1 ng mL−1.
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and R0 is the resistance of aptasensor after immobilization with cTnT aptamers and a blocking agent. The resist-
ance was degraded consistently as the number of uses increased during the first three repeated uses owing to 
aptamer degradation.
To determine the reproducibility of the aptasensors, five samples (100 pg mL−1 in 10-fold diluted human 
serum) were evaluated on the same day and then stored at 4 °C for one week (Table S1). The relative standard 
deviation of the RRC values was measured to be 7.24% within 1 day and 11.29% after 1 week, demonstrating that 
the RRC values were consistent within and between the batches.
We also conducted another test on the adhesion of the fabricated rGO sheets. The resistance changes of the 
present rGO sensors (DEP deposition of GO and its reduction) and those of the sensors fabricated using direct 
deposition of rGO by DEP were measured with the number of times of a washing and nitrogen drying treatment 
(Table 2). The average RRC of the present sensors between the first and the fourth treatments was 4.2%, whereas 
that of the sensors using the direct deposition of rGO by DEP was 64.5%. This result indicates that the present 
rGO sensors using the DEP deposition of GO and its subsequent reduction along with APTES functionalization 
showed better stability than the direct DEP deposition of rGO sheets.
Conclusions
We have demonstrated a low-cost, flexible, highly sensitive and label-free electrical aptasensors using 
DEP-deposited GO and its subsequent reduction to detect the cardiac biomarker troponin T. A few layers (4–10 
layers) of GO were deposited between two predefined Cr/Au electrodes on an APTES-modified, flexible and 
transparent PET substrate by DEP and were reduced to rGO using hydrazine vapour, which did not damage PET 
substrates unlike silicon substrates. In terms of fabricating an rGO channel, DEP deposition of GO and its reduc-
tion was better than the direct DEP deposition of rGO, demonstrating the uniform and robust deposition of both 
GO and its reduced form, rGO, on the PET substrates. Moreover, the DEP process used in this study provided a 
very high yield, and deposition was controlled to a specific location at room temperature within a short time (a 
few seconds), contrasting with other deposition approaches such as drop casting and CVD.
Materials and Methods
Materials and reagents. Graphite (282863), H2SO4 (339741), KMnO4 (223468), H2O2 (216763), HCl 
(H1758), NaNO3 (S5506), 3-aminopropyltriethoxylsilane (APTES) solution (440140), hydrazine solution (35%) 
(309400), ethanolamine (NH2CH2CH2OH; ≥98%) (E9508), Cr etchant (651826), Au etchant (651818), and myo-
globin (MB; M0630) were purchased from Sigma-Aldrich (USA); 5′-amine modified, and 5′-amine/3′-FAM 
(6-carboxy fluorescein) modified cTnT aptamers (091), where the sequence of the aptamers was 5 ′- ATACGG
GAGCCAACACCAGGACTAACATTATAAGAATTGCGAATAATCATTGGAGAGCAGGTGTGACGGAT-3′, 
were obtained from OTC Biotech (USA); cTnT (9202–1107) and cTnI (9202–0707) antigens were obtained from 
AbD-Serotec (USA); normal human serum (S1-100ML) was procured from Merck Millipore (USA); diethylpy-
rocarbonate (DEPC)-treated water (W2004) and dimethylformamide (DMF) (D1021; 98%) were procured from 
Biosesang (South Korea); PBSE (P130) was procured from Thermo Scientific (USA); and PBS (pH 7.4, 10×) was 
procured from Life Technologies (South Korea). DEPC-treated water was used for dilution of the aptamer stock 
solution, which was stored at −20 °C before use. Deionized (DI) water (18.2 MΩ) was prepared from the water 
purification system (Millipore).
Figure 4. Selectivity test of the rGO aptasensors using PBS (pH 7.4, 1×), 10-fold-diluted human serum in PBS 
(pH 7.4, 1×), cTnI (1 µg mL−1), Myoglobin (1 µg mL−1) and cTnT (10 pg mL−1) in the two media. The error bars 
indicate the standard deviations of the measurements. One-way analysis of variance (ANOVA) was used to 
check whether the measured RRCs were significantly different. (ns: p > 0.05 and ***p < 0.0001).
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Go synthesis. GO was obtained using a modified Hummer’s method54,55. In brief, graphite powder (1 g) and 
NaNO3 (0.5 g) were mixed together, and concentrated H2SO4 acid (23 ml, 99.99%) was carefully added under 
stirring at 600 rpm (10 s−1) for 1 h. In addition, KMnO4 (3 g) was added slowly to the solution on a stirrer plate at 
600 rpm, and the solution temperature should be below 20 °C to avoid overheating and an explosion. Then, the 
solution was stirred on a stirrer plate at 600 rpm and 35 °C for 2 h. The resulting solution was mixed with DI water 
(50 mL) under stirring at 1200 rpm (20 s−1), resulting in a dark brown suspension. To make the completion oxida-
tion with KMnO4, the resulting suspension was then mixed with 5 mL of a 30% H2O2 solution, and then DI water 
(100 mL) was added. The solution was treated with 10% HCl and then with DI water, followed by centrifugation 
at 5000 rpm (83 s−1). This washing step was repeated four times for 60 min each. This GO suspension was poured 
onto a glass dish and left to dry in an oven at 80 °C for 24 h, leading to GO powders.
Fabrication of two electrodes and DEP assembly of GO sheets. Two electrodes were fabricated on a 
PET substrate using photolithography and a wet etching process. First, a sheet of PET (thickness: 250 µm, diame-
ter: 100 mm) was cleaned in acetone, methanol, and isopropyl alcohol consecutively for 5 min each. The substrate 
was then rinsed with DI water for 1 min and dried with nitrogen (N2) gas. Deposition of Cr and Au (thicknesses: 
10 nm and 100 nm, respectively) were made consecutively using electron beam evaporation. The electrodes were 
then fabricated by applying Au and Cr etchants consecutively before removing the protective photoresist. The 
gap between these two electrodes was 10 µm, and the width of the facing sides of the two electrodes was 100 µm. 
Finally, this substrate was cut into immunosensor chips, each measuring 10 × 10 mm2. After the chips were 
treated with oxygen plasma for 10 min with a source power of 200 W, APTES solution (2 wt.%) in ethanol was 
Figure 5. Reusability of the aptasensor. Relative resistance change (RRC) of the aptasensors at two 
concentrations of cTnT (10 pg mL−1 to 100 pg mL−1) in PBS (pH 7.4, 1×). The error bars indicate the standard 
deviations of the measurements.
1st gently washing with 
DI water and then 
N2 dry
2nd gently washing 
with DI water and 
then N2 dry
3rd gently washing 
with DI water and 
then N2 dry
4th gently washing with 
DI water and then 
N2 dry
Relative resistance 
change
(1st – 4th) (%)
(Top) Average: 64.58%
8.91 kΩ 9.50 kΩ 10.24 kΩ 13.78 kΩ 54.65
4.57 kΩ 6.11 kΩ 7.00 kΩ 9.15 kΩ 108.0
6.50 kΩ 7.61 kΩ 8.11 kΩ 11.45 kΩ 76.15
5.45 kΩ 6.34 kΩ 7.56 kΩ 7.71 kΩ 41.46
7.87 kΩ 8.40 kΩ 10.05 kΩ 11.22 kΩ 42.56
(Bottom) Average: 4.24%
15.82 kΩ 15.80 kΩ 15.98 kΩ 16.41kΩ 3.72
19.54 kΩ 20.14 kΩ 20.30 kΩ 20.85 kΩ 6.70
14.78 kΩ 14.90 kΩ 14.98 kΩ 15.03 kΩ 1.69
11.21 kΩ 11.32 kΩ 11.85 kΩ 11.90 kΩ 6.15
17.60 kΩ 16.98 kΩ 17.50 kΩ 17.10 kΩ 2.92
Table 2. The comparison between two treatments with the number of times of washing and drying process. 
(Top) Direct deposition of rGO sheets by DEP on a bare PET substrate, and then heating at 150 °C/2 h. (Bottom) 
Direct deposition of GO sheets by DEP on an APTES-coated PET substrate, their reduction (rGO), and then 
heating at 150 °C/2 h.
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pipetted onto the channel area and incubated at RT for 30 min56. The chips were then rinsed with DI water and 
dried with a N2 gas stream.
GO suspension was made by suspending the synthesized GO powder in DI water (10 µg mL−1) by using 60 min 
sonication (Bransonic, 5510) to remove any aggregates, centrifuging the solution at 5000 rpm (83 s−1) for 30 min, 
and then collecting the supernatant. After pipetting 10 µL of the collected GO suspension between the predefined 
Cr/Au electrodes coated with APTES, providing additional adhesion between PET and GO surfaces, a thin film 
of GO sheets was created by supplying 10 Vpp (peak-to-peak) at 500 kHz for 30 s (Fig. 1A).
Reduction of Go sheets on a pet substrate. The DEP-deposited GO film on a PET substrate was 
reduced to rGO by treating with hydrazine vapour. First, the purchased hydrazine solution was diluted with DI 
water to make 20 mL of a 15% (v/v) hydrazine solution. The chips with GO were moved into a small glass petri 
dish, which was kept inside a larger glass petri dish containing the hydrazine solution. The larger dish was covered 
with a glass lid and a parafilm tape, and kept on a hot plate at 90 °C for 18 h48. Afterwards, the dish was removed 
and the chips were thoroughly rinsed with DI water. After this reduction step, the chips were immediately placed 
in a vacuum oven at 150 °C for 2 h, in order to remove the residue and enhance the adhesion between the rGO 
sheets and the electrodes.
Channel functionalization, resistance measurements, and reusability test. The chips were thor-
oughly rinsed with DI water, dried with N2 gas, and then incubated with 5 mM of PBSE (linker) in DMF at RT for 
1 h, followed by treating with DMF and DI water consecutively. PBSE provides pyrene groups for π–π interactions 
to the planes of rGO sheets, leading to stable noncovalent interaction via π-electron donating and accepting, and 
its terminal functional group remains free, allowing covalent attachment of biomolecules due to their amine 
groups. The chips were then incubated in 5′-amine–modified DNA cTnT aptamers (10 µg mL−1) in DEPC-treated 
water at 37 °C for 2 h, thoroughly rinsed with PBS (pH 7.4, 1×) to remove loosely attached aptamers, and then 
air-dried at RT for 5 min. The cTnT aptamer was covalently attached via binding of −NH2 groups with succinim-
ide ester generated on the graphene surface. The chips were then incubated in ethanolamine (100 mM) at RT for 
1 h to preclude possible non-specific binding on the rGO surface, and then rinsed with PBS (pH 7.4, 1×). cTnT 
(10 ng mL−1 to 1 pg mL−1) in PBS (pH 7.4, 1×) and in human serum (10-fold diluted) with PBS (pH 7.4, 1×) was 
applied to measure the RRC of the aptasensors (Fig. 1B,C). The rGO surfaces were also incubated in 5′-amine 
and 3′-FAM-modified cTnT aptamers with the same sequence used for cTnT detection (10 µg mL−1) diluted in 
DEPC-treated water at 37 °C for 2 h, followed by rinsing with PBS (pH 7.4, 1×), and air-dried at RT, to obtain a 
fluorescence image of the aptamers deposited on the channels. Figure 1B shows a diagram of the rGO aptasensor 
for the detection of cTnT.
RRC is defined as ΔR = (R − R0)/R0, where R is the resistance of aptasensor after cTnT immobilization, and 
R0 is the resistance of aptasensor after immobilization with the cTnT aptamer and blocking agent. All electrical 
measurements were performed with a Keithley 2636B source meter. The current–voltage (I–V) measurements of 
the rGO aptasensors were performed from −2.0 V to + 2.0 V at each step of functionalization on the rGO surface.
The reusability of the aptasensors was evaluated, and the tests consisted of the following steps: the immobili-
zation of cTnT (100 and 10 pg mL−1) in 1× PBS on the aptasensors followed by rinsing with PBS and resistance 
measurements, and the addition of a 10% NaCl for 15 min, followed by rinsing with DEPC-treated water, dissoci-
ating the cTnT-aptamer complexes without detaching the aptamer57.
Characterization of rGO aptasensor. The DEP-deposited GO sheets and their reduced sheets (rGO) 
were characterized by a tapping mode atomic force microscope (Bruker Instrument, USA) and Raman spec-
troscopy (300R, WITec, Germany). A field emission scanning electron microscope (FE-SEM; S-4800, Hitachi, 
Japan) was used to image the GO and rGO sheets between the two electrodes. The samples were platinum-coated 
with ion sputtering (E-1045, Hitachi, Japan) before FE-SEM imaging. The chemical bonding of the synthesized 
GO and rGO sheets were studied by X-ray photoelectron spectroscopy (XPS; K-Alpha, Thermo Scientific, USA). 
Optical transmission of the aptasensors was estimated with ultraviolet–visible–near-infrared spectroscopy (UV–
vis–NIR; Cary 5000, Agilent, USA). Optical images were also obtained with an optical microscope (Eclipse 80i, 
Nikon, Japan) and a charge-coupled device (CCD) camera (CoolSNAP HQ2 Monochrome, Photometrics, USA). 
Fluorescence images were taken using a multiphoton confocal laser scanning microscope (ZEISS LSM780 NLO, 
Germany).
statistical analysis. Each experiment was analysed with four aptasensors (n = 5 replicates). The averaged 
values with their standard deviations (indicated as error bars) are shown in the figures. One-way analysis of var-
iance (ANOVA) was used to determine whether the measured RRCs were significantly different between cTnT 
concentrations, and they were counted significantly different for p < 0.05.
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